Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study

Background: Bladder cancer is the most common malignancy of the urinary tract. Calcitriol [1,25 (OH)2vitamin D3] has anticancer effects mediated through binding to vitamin D receptor (VDR). The expression of VDR is present in many normal and cancer tissues. But, there is little information about its...

Full description

Bibliographic Details
Main Authors: Rehab Mohamed Sharaf, Basma Mostafa Mahmoud Abdalla, Samia Ibrahim El Naggar, Wesam Ismail Moustafa
Format: Article
Language:English
Published: West Asia Organization for Cancer Prevention 2022-09-01
Series:Asian Pacific Journal of Cancer Biology
Subjects:
Online Access:http://www.waocp.com/journal/index.php/apjcb/article/view/916
_version_ 1827368677548228608
author Rehab Mohamed Sharaf
Basma Mostafa Mahmoud Abdalla
Samia Ibrahim El Naggar
Wesam Ismail Moustafa
author_facet Rehab Mohamed Sharaf
Basma Mostafa Mahmoud Abdalla
Samia Ibrahim El Naggar
Wesam Ismail Moustafa
author_sort Rehab Mohamed Sharaf
collection DOAJ
description Background: Bladder cancer is the most common malignancy of the urinary tract. Calcitriol [1,25 (OH)2vitamin D3] has anticancer effects mediated through binding to vitamin D receptor (VDR). The expression of VDR is present in many normal and cancer tissues. But, there is little information about its expression in urinary bladder carcinoma. This study aimed to analyze VDR immunohistochemical expression in 74 Egyptian patients with urinary bladder carcinoma and to evaluate its association with different clinicopathological parameters. Methods: Sections from formalin-fixed, paraffin-embedded tumor blocks were stained immunohistochemically using monoclonal anti-VDR antibody. VDR protein expression as well as its immunostaining patterns were recorded and scored separately in each case using semi-quantitative immunoreactive score. Results: VDR was consistently expressed in the included histologically normal urothelium while tumor cells showed variable degrees of expression. Cytoplasmic/membranous VDR expression was common among the studied cases especially those with urothelial morphology (p = 0.076). While, the mean nuclear VDR was significantly (p = 0.007) higher in non-urothelial tumors. Nuclear VDR was significantly associated with muscle invasion (p = 0.000) and tumor stage (p = 0.001) in urothelial carcinoma. It was also statistically related to tumor grade, stage and muscle invasion in non-urothelial tumors (p = 0.002, 0.003 and 0.012, respectively). Conclusion: there was a significant relation between nuclear VDR expression and prognostic markers suggesting its decrease as an indicator of a poorer prognosis. Vitamin D supplementation may represent a new treatment option for patients with bladder cancer.
first_indexed 2024-03-08T09:35:31Z
format Article
id doaj.art-20c27b83724243f089219824ac29115e
institution Directory Open Access Journal
issn 2538-4635
language English
last_indexed 2024-03-08T09:35:31Z
publishDate 2022-09-01
publisher West Asia Organization for Cancer Prevention
record_format Article
series Asian Pacific Journal of Cancer Biology
spelling doaj.art-20c27b83724243f089219824ac29115e2024-01-30T09:28:52ZengWest Asia Organization for Cancer PreventionAsian Pacific Journal of Cancer Biology2538-46352022-09-017324525310.31557/apjcb.2022.7.3.245-253916Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological StudyRehab Mohamed Sharaf0Basma Mostafa Mahmoud Abdalla1Samia Ibrahim El Naggar2Wesam Ismail Moustafa3Department of Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.Department of Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.Department of Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.Department of Pathology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.Background: Bladder cancer is the most common malignancy of the urinary tract. Calcitriol [1,25 (OH)2vitamin D3] has anticancer effects mediated through binding to vitamin D receptor (VDR). The expression of VDR is present in many normal and cancer tissues. But, there is little information about its expression in urinary bladder carcinoma. This study aimed to analyze VDR immunohistochemical expression in 74 Egyptian patients with urinary bladder carcinoma and to evaluate its association with different clinicopathological parameters. Methods: Sections from formalin-fixed, paraffin-embedded tumor blocks were stained immunohistochemically using monoclonal anti-VDR antibody. VDR protein expression as well as its immunostaining patterns were recorded and scored separately in each case using semi-quantitative immunoreactive score. Results: VDR was consistently expressed in the included histologically normal urothelium while tumor cells showed variable degrees of expression. Cytoplasmic/membranous VDR expression was common among the studied cases especially those with urothelial morphology (p = 0.076). While, the mean nuclear VDR was significantly (p = 0.007) higher in non-urothelial tumors. Nuclear VDR was significantly associated with muscle invasion (p = 0.000) and tumor stage (p = 0.001) in urothelial carcinoma. It was also statistically related to tumor grade, stage and muscle invasion in non-urothelial tumors (p = 0.002, 0.003 and 0.012, respectively). Conclusion: there was a significant relation between nuclear VDR expression and prognostic markers suggesting its decrease as an indicator of a poorer prognosis. Vitamin D supplementation may represent a new treatment option for patients with bladder cancer.http://www.waocp.com/journal/index.php/apjcb/article/view/916vdr, immunohistochemistry, urinary bladder, urothelial carcinoma, non-urothelial carcinoma
spellingShingle Rehab Mohamed Sharaf
Basma Mostafa Mahmoud Abdalla
Samia Ibrahim El Naggar
Wesam Ismail Moustafa
Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
Asian Pacific Journal of Cancer Biology
vdr, immunohistochemistry, urinary bladder, urothelial carcinoma, non-urothelial carcinoma
title Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
title_full Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
title_fullStr Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
title_full_unstemmed Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
title_short Expression of Vitamin D Receptor (VDR) in Urinary Bladder Carcinoma: Immunohistochemical and Histopathological Study
title_sort expression of vitamin d receptor vdr in urinary bladder carcinoma immunohistochemical and histopathological study
topic vdr, immunohistochemistry, urinary bladder, urothelial carcinoma, non-urothelial carcinoma
url http://www.waocp.com/journal/index.php/apjcb/article/view/916
work_keys_str_mv AT rehabmohamedsharaf expressionofvitamindreceptorvdrinurinarybladdercarcinomaimmunohistochemicalandhistopathologicalstudy
AT basmamostafamahmoudabdalla expressionofvitamindreceptorvdrinurinarybladdercarcinomaimmunohistochemicalandhistopathologicalstudy
AT samiaibrahimelnaggar expressionofvitamindreceptorvdrinurinarybladdercarcinomaimmunohistochemicalandhistopathologicalstudy
AT wesamismailmoustafa expressionofvitamindreceptorvdrinurinarybladdercarcinomaimmunohistochemicalandhistopathologicalstudy